Efficacy and safety of Salmeterol/Fluticasone DPI HEXAL versus Seretide Accuhaler in adolescent and adult patients with moderate-to-severe persistent asthma: A 12-week, multicenter, randomized, double-blind, double-dummy, parallel group study.
Phase of Trial: Phase III
Latest Information Update: 29 May 2013
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors HEXAL
- 29 May 2013 Primary endpoint 'Forced-expiratory-volume-in-1-second' has been met.
- 29 May 2013 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met.
- 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.